As for human studies, previous studies have demonstrated that mRNA expression of KLK10 was lower in breast cancer tissues [28], compared to normal tissues, whereas upregulation of KLK10 was associated with a poor prognosis or cancer diagnosis for other cancers including ovarian, pancreatic and colorectal cancers [29–31]. The gene discussed is KLK10; the disease is breast cancer.